Home/MeMed/Barak Hershkovitz, MD
BH

Barak Hershkovitz, MD

Chief Technology Officer

MeMed

MeMed Pipeline

DrugIndicationPhase
MeMed BVBacterial vs Viral Infection DifferentiationCommercial
MeMed SeverityRisk Stratification for Acute Infection DeteriorationCE‑marked / FDA‑clearance pending
MeMed KeyPlatform for Multiplex Protein MeasurementCommercial